Heather Smith, APRN
Family · Greensburg, KYNPI 1699283382
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 55.0% of the total. Reporting peaked in 2021 at $96 and has fallen 81.0% since, to $18 in 2025. That places this record below the midpoint for family clinicians in KY, where the typical reported total is $464.
Across 15 payments — averaging $16.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$136
- Avanir Pharmaceuticals, Inc.$32
- AbbVie$30
- Takeda Pharmaceuticals U.S.A., Inc.$19
- Intercept Pharmaceuticals, Inc.$17
- Kowa Pharmaceuticals America, Inc.$13
What the payments were for
- Food & beverage$247100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$247 in reported general payments places this provider in the 35th percentile of 4,374 family providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 138 | $83,466 |
| FarxigaDapagliflozin Propanediol | 112 | $66,323 |
| JanuviaSitagliptin Phosphate | 44 | $31,757 |
| TrulicityDulaglutide | 21 | $20,726 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $19,770 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 47 | $19,236 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 55 | $16,295 |
| DapagliflozinDapagliflozin Propanediol | 40 | $14,593 |
| EntrestoSacubitril/Valsartan | 20 | $11,725 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 73 | $9,648 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 97 | $8,929 |
| GlucagenGlucagon | 25 | $8,167 |
| Divalproex Sodium | 144 | $7,672 |
| Mirtazapine | 218 | $7,013 |
| Buspirone Hcl | 270 | $6,777 |
Paid to pharmacies, not to this prescriber.
Other family in Greensburg
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
- Carrie Parrish NyekanBowling Green$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.